Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial

Naim Alkhouri, Robert Herring, Heidi Kabler, Zeid Kayali, Tarek Hassanein, Anita Kohli, Ryan S. Huss, Yanni Zhu, Andrew N. Billin, Lars Holm Damgaard, Kristine Buchholtz, Mette Skalshøi Kjær, Clare A. Balendran, Robert P. Myers, Rohit Loomba, Mazen Noureddin